Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins

People 18 years of age and older who are interested in participating in this trial can visit coronaviruspreventionnetwork.org or ClinicalTrials.gov and search identifier NCT04516746 for details. Please do not contact the NIAID media phone number or email to enroll in this trial. A multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222 has begun. The trial will enroll approximately 30,000 adult volunteers at 80 sites in the United States to e… Read More